Phase I/II Study of Cisplatin plus Romidepsin and Nivolumab in Metastatic Triple Negative Breast Cancer or BRCA Mutation-Associated Locally Recurrent or Metastatic Breast Cancer

Brief Summary

Type:
Breast Cancer

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT02393794

Study #:
STUDY00002219

Start Date:
Jan 01, 0001

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02393794

View Complete Trial Details & Eligibility at ClinicalTrials.gov